IL105556A0 - 4-or 5-(sulf)imido-and-(sulfon)amidopyridines and their pyridine n-oxides,processes for their preparation,and their use as medicaments - Google Patents

4-or 5-(sulf)imido-and-(sulfon)amidopyridines and their pyridine n-oxides,processes for their preparation,and their use as medicaments

Info

Publication number
IL105556A0
IL105556A0 IL105556A IL10555693A IL105556A0 IL 105556 A0 IL105556 A0 IL 105556A0 IL 105556 A IL105556 A IL 105556A IL 10555693 A IL10555693 A IL 10555693A IL 105556 A0 IL105556 A0 IL 105556A0
Authority
IL
Israel
Prior art keywords
amidopyridines
sulfon
sulf
imido
medicaments
Prior art date
Application number
IL105556A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL105556A0 publication Critical patent/IL105556A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL105556A 1992-04-30 1993-04-29 4-or 5-(sulf)imido-and-(sulfon)amidopyridines and their pyridine n-oxides,processes for their preparation,and their use as medicaments IL105556A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4214465 1992-04-30
DE4224440 1992-07-24

Publications (1)

Publication Number Publication Date
IL105556A0 true IL105556A0 (en) 1993-08-18

Family

ID=25914462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105556A IL105556A0 (en) 1992-04-30 1993-04-29 4-or 5-(sulf)imido-and-(sulfon)amidopyridines and their pyridine n-oxides,processes for their preparation,and their use as medicaments

Country Status (12)

Country Link
EP (1) EP0567997A1 (cs)
JP (1) JPH0687831A (cs)
KR (1) KR940005576A (cs)
CN (1) CN1079466A (cs)
AU (1) AU3822593A (cs)
CA (1) CA2095206A1 (cs)
CZ (1) CZ78093A3 (cs)
FI (1) FI931907A7 (cs)
HU (2) HU9301240D0 (cs)
IL (1) IL105556A0 (cs)
NO (1) NO931560L (cs)
PL (1) PL298749A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
SG11201408284VA (en) 2012-05-22 2015-02-27 Xenon Pharmaceuticals Inc N-substituted benzamides and their use in the treatment of pain
US10071957B2 (en) 2012-07-06 2018-09-11 Genentech, Inc. N-substituted benzamides and methods of use thereof
CN104478798B (zh) * 2014-12-18 2017-01-18 武汉华纳联合药业有限公司 N‑氨基烷基磺酰基‑3‑吡啶甲酰胺衍生物及其在制备治疗心脑血管病药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
EP0533130A1 (de) * 1991-09-19 1993-03-24 Hoechst Aktiengesellschaft 2-Hydroxymethylpyridine, die entsprechenden Pyridin-N-oxide und ihre Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung

Also Published As

Publication number Publication date
NO931560L (no) 1993-11-01
FI931907A0 (fi) 1993-04-28
FI931907L (fi) 1993-10-31
CZ78093A3 (en) 1994-01-19
KR940005576A (ko) 1994-03-21
NO931560D0 (no) 1993-04-29
EP0567997A1 (de) 1993-11-03
FI931907A7 (fi) 1993-10-31
CA2095206A1 (en) 1993-10-31
HU210710A9 (en) 1995-06-28
AU3822593A (en) 1993-11-04
HU9301240D0 (en) 1993-07-28
CN1079466A (zh) 1993-12-15
PL298749A1 (en) 1993-12-13
JPH0687831A (ja) 1994-03-29

Similar Documents

Publication Publication Date Title
AU589190B2 (en) Heterocyclic substituted-phenoxyalkyl-isoxazoles and furans, their preparation and use as antiviral agents
AU4540389A (en) Quinuclidines, their use as medicaments and processes for their preparation
AU582113B2 (en) Furo-(3,4-C)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
AU2010188A (en) Pyridinium derivatives, their production and use
AU7849387A (en) 2- or-3- aryl substituted imidazo(1,2-a)pyridines
AU644538B2 (en) Pyridine derivatives, their production and use
AU2456792A (en) 2-hydroxymethylpyridines, the corresponding pyridine n-oxides and their derivatives, processes for their preparation and their use
AU3352593A (en) Pyridine derivatives, their preparation and use as medicines
IL100115A0 (en) Isonicotinic acid derivatives and related spirocompounds,their preparation and their use as herbicides
AU1145088A (en) Pyridine-2,4- and -2,5-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds
AU697355B2 (en) Substituted pyridines and pyrimidines, processes for their preparation and their use as pesticides and fungicides
AU3039192A (en) Substituted pyridine n-oxides, processes for their preparation, and their use
IL81042A0 (en) Pyridine derivatives and n-oxides thereof,processes for their preparation and the use thereof as intermediates
EP0479177A3 (en) 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments
AU1532288A (en) Substitute tetrahydropthalimides, processes for their preparation and their use as herbicides
IL105556A0 (en) 4-or 5-(sulf)imido-and-(sulfon)amidopyridines and their pyridine n-oxides,processes for their preparation,and their use as medicaments
AU4614289A (en) Substituted pyridazinones, processes for their preparation, and their use as pesticides
AU1630188A (en) Substituted compounds, processes for their preparation and their use as medicaments
ZA932983B (en) 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine N-oxides, processes for their preparation, and their use as medicaments
AU3168089A (en) Azaneophyl and silazaneophyl sulfides, processes for their preparation, agents containing them, and their use as pesticides
IL86794A0 (en) Pyridine compounds,their preparation and their use as herbicides
AU588409B2 (en) Pyridine derivatives, processes for the preparation thereof, agents containing same, and the use thereof as pesticides
AU6886891A (en) Pyridine derivatives, process for making them, agents containing them and their use as fungicides
AU7311087A (en) Pyrazolo{3,4-6} pyridine derivatives
IL96706A0 (en) 3-substituted pyridines,their manufacture and their use as fungicides